Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis 0 23.09.2025 07:39 The New York Times Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
